Epidemiology of Hepatitis C Virus Among Long-Term Dialysis Patients: A 9-Year Study in an Italian Region

American Journal of Kidney Diseases

Volumn 48, Issue 4, 2006, Pages 629-637

  Di Napoli, Anteo ^a   Pezzotti, Patrizio ^a   Di Lallo, Domenico ^a   Petrosillo, Nicola ^a   Trivelloni, Claudia ^a   Di Giulio, Salvatore ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

epidemiology; Hepatitis C virus (HCV) infection; long term dialysis; prevalence; seroconversion; survival

Indexed keywords

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIALYSIS; FEMALE; HEPATITIS C; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PROBABILITY; REGISTER; RISK ASSESSMENT; SEROCONVERSION; SURVIVAL;

AGED; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; ITALY; KIDNEY DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33748746666     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.07.004     Document Type: Article

References (33)

1. Saab S. Hepatitis C virus transmission in the hemodialysis community. Am J Kidney Dis 37 (2001) 1052-1055
2. Meyers C.M., Seeff L.B., Stehman-Breen C.O., and Hoofnagle J.H. Hepatitis C and renal disease: An update. Am J Kidney Dis 42 (2003) 631-636
3. Bergman S., Accortt N., Turner A., and Glaze J. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis 45 (2005) 684-689
4. Fissell R.B., Bragg-Gresham J.L., Woods J.D., et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int 65 (2004) 2335-2342
5. Kalantar-Zadeh K., Miller L.G., and Daar E.S. Diagnostic discordance for hepatitis C virus infection in hemodialysis patients. Am J Kidney Dis 46 (2005) 290-300
6. Di Lallo D., Miceli M., Petrosillo N., Perucci C.A., and Moscatelli M. Risk factors of hepatitis C virus infection in patients on hemodialysis: A multivariate analysis based on a dialysis register in Central Italy. Eur J Epidemiol 15 (1999) 11-14
7. Petrosillo N., Gilli P., Serraino D., et al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 37 (2001) 1004-1010
8. McLaughlin K.J., Cameron S.O., Good T., et al. Nosocomial transmission of hepatitis C virus within a British dialysis centre. Nephrol Dial Transplant 12 (1997) 304-309
9. Di Lallo D., Miceli M., and Perucci C.A. [The descriptive epidemiology of patients with kidney failure on chronic dialysis treatment. The results of the Lazio Population Registry. The Lazio Dialysis Registry]. Epidemiol Prev 21 (1997) 194-201
10. Di Napoli A., Pezzotti P., Di Lallo D., Tancioni V., Papini P., and Guasticchi G. Determinants of hospitalization in a cohort of chronic dialysis patients in central Italy. J Nephrol 18 (2005) 21-29
11. Hosmer D.W., and Lemeshow S. Applied Logistic Regression. (ed 2) (2000), Wiley, New York, NY
12. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
13. Cox D.R. Regression models and life tables. J R Stat Soc B 34 (1972) 187-220
14. Hamilton L.C. Statistics with STATA 8. (ed 5) (2003), Duxbury Press, Southbank, Victoria; Belmont, CA
15. Forns X., Fernandez-Llama P., Costa J., et al. Hepatitis G virus infection in a haemodialysis unit: Prevalence and clinical implications. Nephrol Dial Transplant 12 (1997) 956-960
16. Tokars J.I., Finelli L., Alter M.J., and Arduino M.J. National surveillance of dialysis-associated diseases in the United States, 2001. Semin Dial 17 (2004) 310-319
17. Espinosa M., Martn-Malo A., Ojeda R., et al. Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: Causes and consequences. Am J Kidney Dis 43 (2004) 685-689
18. Jadoul M., Poignet J.L., Geddes C., et al. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 19 (2004) 904-909
19. Fabrizi F., Martin P., Dixit V., et al. Acquisition of hepatitis C virus in hemodialysis patients: A prospective study by branched DNA signal amplification assay. Am J Kidney Dis 31 (1998) 647-654
20. National Kidney Foundation. DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure. Am J Kidney Dis 30 suppl 3 (1997) S192-S240
21. Triolo G., Canavese C., and Di Giulio S. Reasons for producing guidelines on anemia of chronic renal failure: Dialysis Outcome Quality Initiative of the National Kidney Foundation. Int J Artif Organs 21 (1998) 751-756
22. Froio N., Nicastri E., Comandini U.V., et al. Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis 42 (2003) 546-550
23. Arenas Jimenez M.D., Sanchez Paya J., Gonzalez C., Rivera F., and Enriquez R. Isolation of HCV patient is efficient in reducing the annual incidence of HCV infection, but is it really necessary?. Nephrol Dial Transplant 14 (1999) 1337-1339
24. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Morb Mortal Wkly Rep 50 RR-5 (2001) 1-43
25. Katsoulidou A., Paraskevis D., Kalapothaki V., et al. Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 14 (1999) 1188-1194
26. Sypsa V., Psichogiou M., Katsoulidou A., et al. Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients. Am J Kidney Dis 45 (2005) 334-343
27. Pillonel J., and Laperche S. Etablissement Francais du sang: Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT). Euro Surveill 10 (2005) 5-8
28. Stehman-Breen C.O., Emerson S., Gretch D., and Johnson R.J. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 32 (1998) 629-634
29. Nakayama E., Akiba T., Marumo F., and Sato C. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 11 (2000) 1896-1902
30. Kalantar-Zadeh K., McAllister C.J., and Miller L.G. Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: A population based study. Nephrol Dial Transplant 20 (2005) 1662-1669
31. Pereira B.J., Natov S.N., Bouthot B.A., et al., The New England Organ Bank Hepatitis C Study Group. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 53 (1998) 1374-1381
32. Geddes C.C., Van Dijk P.C., McArthur S., et al. The ERA-EDTA cohort study. Comparison of methods to predict survival on renal replacement therapy. Nephrol Dial Transplant 21 (2006) 945-956
33. Martin P., and Fabrizi F. Treatment of chronic hepatitis C infection in patients with renal failure. Clin Gastroenterol Hepatol 3 suppl 2 (2005) S113-S117